These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11595631)

  • 21. Molecular Mechanisms of Mast Cell Activation by Cholesterol-Dependent Cytolysins.
    Draberova L; Tumova M; Draber P
    Front Immunol; 2021; 12():670205. PubMed ID: 34248949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More than a pore: the cellular response to cholesterol-dependent cytolysins.
    Cassidy SK; O'Riordan MX
    Toxins (Basel); 2013 Apr; 5(4):618-36. PubMed ID: 23584137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy.
    Ohkura K; Nagamune H; Kourai H
    Anticancer Res; 2004; 24(5C):3343-53. PubMed ID: 15515430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct Neurotoxicity Profile of Listeriolysin O from Listeria monocytogenes.
    Maurer J; Hupp S; Bischoff C; Foertsch C; Mitchell TJ; Chakraborty T; Iliev AI
    Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28098781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin.
    Ramachandran R; Heuck AP; Tweten RK; Johnson AE
    Nat Struct Biol; 2002 Nov; 9(11):823-7. PubMed ID: 12368903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae.
    Rossjohn J; Gilbert RJ; Crane D; Morgan PJ; Mitchell TJ; Rowe AJ; Andrew PW; Paton JC; Tweten RK; Parker MW
    J Mol Biol; 1998 Nov; 284(2):449-61. PubMed ID: 9813129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins.
    Tweten RK
    Infect Immun; 2005 Oct; 73(10):6199-209. PubMed ID: 16177291
    [No Abstract]   [Full Text] [Related]  

  • 28. The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity.
    Pinkney M; Beachey E; Kehoe M
    Infect Immun; 1989 Aug; 57(8):2553-8. PubMed ID: 2663727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thiol-dependent cytolytic bacterial toxins: streptolysin O and prominent toxins].
    Alouf JE
    Arch Inst Pasteur Tunis; 1981; 58(3):355-73. PubMed ID: 6172081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermedilysin cytolytic activity depends on heparan sulfates and membrane composition.
    Drabavicius G; Daelemans D
    PLoS Genet; 2021 Feb; 17(2):e1009387. PubMed ID: 33577603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonate inhibitors of squalene synthase protect cells against cholesterol-dependent cytolysins.
    Pospiech M; Owens SE; Miller DJ; Austin-Muttitt K; Mullins JGL; Cronin JG; Allemann RK; Sheldon IM
    FASEB J; 2021 Jun; 35(6):e21640. PubMed ID: 33991130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess.
    Nagamune H; Ohnishi C; Katsuura A; Fushitani K; Whiley RA; Tsuji A; Matsuda Y
    Infect Immun; 1996 Aug; 64(8):3093-100. PubMed ID: 8757839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol-Dependent Cytolysins: Membrane and Protein Structural Requirements for Pore Formation.
    Morton CJ; Sani MA; Parker MW; Separovic F
    Chem Rev; 2019 Jul; 119(13):7721-7736. PubMed ID: 31244002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hydrophobic character of thiol-activated cytolysins.
    Johnson MK; Knight RJ; Drew GK
    Biochem J; 1982 Dec; 207(3):557-60. PubMed ID: 7165708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pore-forming bacterial cytolysins.
    Bhakdi S; Valeva A; Walev I; Zitzer A; Palmer M
    Symp Ser Soc Appl Microbiol; 1998; 27():15S-25S. PubMed ID: 9750358
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction of Cholesterol with Perfringolysin O: What Have We Learned from Functional Analysis?
    Savinov SN; Heuck AP
    Toxins (Basel); 2017 Nov; 9(12):. PubMed ID: 29168745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure and molecular mechanism of a functional form of pneumolysin: a cholesterol-dependent cytolysin from Streptococcus pneumoniae.
    Kelly SJ; Jedrzejas MJ
    J Struct Biol; 2000 Oct; 132(1):72-81. PubMed ID: 11121308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae.
    Gilbert RJ; Jiménez JL; Chen S; Tickle IJ; Rossjohn J; Parker M; Andrew PW; Saibil HR
    Cell; 1999 May; 97(5):647-55. PubMed ID: 10367893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane interactions and cellular effects of MACPF/CDC proteins.
    Cajnko MM; Mikelj M; Turk T; Podobnik M; Anderluh G
    Subcell Biochem; 2014; 80():119-44. PubMed ID: 24798010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell recognition of listeriolysin O is induced during infection with Listeria monocytogenes.
    Berche P; Gaillard JL; Geoffroy C; Alouf JE
    J Immunol; 1987 Dec; 139(11):3813-21. PubMed ID: 3119720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.